Loading...
Bone Biologics Corporation
BBLGW•NASDAQ
HealthcareMedical - Devices
$20.20
$4.60(29.49%)
Bone Biologics Corporation (BBLGW) Financial Performance & Statements
Review Bone Biologics Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
55.25%
↑ 55.25%
Net Income Growth
18.15%
↑ 18.15%
Operating Cash Flow Growth
56.83%
↑ 56.83%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-228.35%
↓ 228.35%
ROIC
-149.58%
↓ 149.58%
Bone Biologics Corporation (BBLGW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bone Biologics Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $1.10M | $429747.00 | $350442.00 | $245625.00 |
| SG&A Expenses | $450368.00 | $521274.00 | $459223.00 | $657911.00 |
| Operating Expenses | $1.55M | $951021.00 | $809665.00 | $903536.00 |
| Total Costs & Expenses | -$2.66M | $951021.00 | $809665.00 | $903536.00 |
| Interest Income | $20265.00 | $19993.00 | $15147.00 | $255.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$903541.00 | $0.00 | $5.00 | $903536.00 |
| EBITDA | -$2.46M | -$951021.00 | -$809660.00 | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$1.55M | -$951021.00 | -$809665.00 | -$903540.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$3.18M | $10019.00 | $25932.00 | $37566.00 |
| Income Before Tax | -$4.73M | -$941002.00 | -$783733.00 | -$865970.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $903536.00 | $0.00 | $0.00 | -$903536.00 |
| Net Income | -$4.73M | -$941002.00 | -$783733.00 | -$865970.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.48 | -$2.37 | -$0.67 | -$1.31 |
| Diluted EPS | -$0.48 | -$2.37 | -$0.67 | -$1.31 |
| Weighted Avg Shares Outstanding | $1.52M | $1.75M | $1.17M | $660000.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.52M | $1.75M | $1.17M | $660928.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan